Oncology Clinical Trials in Kansas City, MO

As of August 2026, 89 paid clinical trials are recruiting for Oncology in Kansas City, Missouri. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 27, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

Newly added in Kansas City

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

Advancing Patient Care for Lymphatic Pain and Lymphedema

for Breast Cancer

1 location in Kansas City

Sponsor: University of Missouri, Kansas City

Sex: All·Age: 18 - 89

Code: NCT07701018·Not Yet Recruiting·Listed Jul 14, 2026

90 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Kansas City, MO.

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Cancer

Drug: daraxonrasib

Sites in Kansas City +34 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07252232·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

for Carcinoma, Hepatocellular

Drug: PF-08634404

Sites in Kansas City, Creve Coeur +39 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227012·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

for Breast Neoplasms

Sites in Kansas City, Springfield +123 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT07174336·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for Breast Neoplasms

Drug: Pumitamig

Sites in Kansas City +63 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT07173751·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Carcinoma, Non-Small-Cell Lung

Drug: Amivantamab

Sites in Kansas City, Springfield +126 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for Breast Neoplasms

Sites in Kansas City, St Louis +58 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06966700·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for Breast Cancer

Sites in Kansas City +58 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for Chronic Lymphocytic Leukemia

Drug: Nemtabrutinib

Sites in Kansas City +42 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06136559·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

for Breast Neoplasms

Sites in Kansas City, St Louis +39 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06312176·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

for Large B-cell Lymphoma

Sites in Kansas City, Columbia +59 more locations

Sponsor: Allogene Therapeutics

Sex: All·Age: 18+

Code: NCT06500273·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

for Non-Small Cell Lung Cancer

Drug: sigvotatug vedotin

Sites in Kansas City, Lee's Summit +73 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06758401·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

for Breast Neoplasms

Sites in Kansas City +37 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06926868·Phase 2, Phase 3·Recruiting·Listed Apr 2025

Apply to this trial

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

for Diffuse Large B-Cell Lymphoma

Drug: Rituximab

Sites in Kansas City, Bridgeton +43 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06717347·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

for Breast Cancer

Sites in Kansas City, Florissant +100 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07062965·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

for Hormone Receptor Positive HER-2 Negative Breast Cancer

Sites in Kansas City, Columbia +32 more locations

Sponsor: Puma Biotechnology, Inc.

Sex: All·Age: 18+

Code: NCT06369285·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

for Colorectal Cancer

Sites in Kansas City, St Louis +30 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06562543·Phase 4·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for Non-small Cell Lung Cancer

Drug: Relatlimab

Sites in Kansas City +39 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06561386·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

for Non Small Cell Lung Cancer

Drug: Telisotuzumab Vedotin

Sites in Kansas City, Springfield +7 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT04928846·Phase 3·Recruiting·Listed Jun 2021

Apply to this trial

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for Multiple Myeloma

Drug: Daratumumab

Sites in Kansas City +65 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05552222·Phase 3·Recruiting·Listed Sep 2022

Apply to this trial

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

for Neoplasms

Sites in Kansas City +24 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 39

Code: NCT05999994·Phase 2·Recruiting·Listed Aug 2023

Apply to this trial

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for Breast Cancer

Sites in Kansas City, St Louis +22 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05768139·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

for Myelodysplastic Syndrome

Sites in Kansas City, Lee's Summit +39 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT04227847·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

for Breast Cancer

Drug: Palazestrant

Sites in Kansas City +32 more locations

Sponsor: Olema Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07085767·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for Metastatic Breast Cancer

Sites in Kansas City, St Louis +29 more locations

Sponsor: LeonaBio

Sex: All·Age: 18+

Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

Drug: Ivonescimab

Sites in Kansas City, St Louis +92 more locations

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for HER2 Mutation-Related Tumors

Sites in Kansas City, St Louis +27 more locations

Sponsor: Iambic Therapeutics, Inc

Sex: All·Age: 18+

Code: NCT06253871·Phase 1·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

for Chronic Lymphocytic Leukemia

Drug: Venetoclax

Sites in Kansas City +30 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06428019·Phase 3·Recruiting·Listed May 2024

Apply to this trial

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for Multiple Myeloma

Drug: Elranatamab

Sites in Kansas City, Independence +91 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06152575·Phase 3·Recruiting·Listed Nov 2023

Apply to this trial

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for Breast Cancer

Sites in Kansas City +52 more locations

Sponsor: Exact Sciences Corporation

Sex: All·Age: 18+

Code: NCT06401421·Recruiting·Listed May 2024

Apply to this trial

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for Cancer, Metastatic

Sites in Kansas City, St Louis +65 more locations

Sponsor: Massive Bio, Inc.

Sex: All·Age: All ages

Code: NCT03452774·Recruiting·Listed Mar 2018

Apply to this trial

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for Myelodysplastic Syndrome

Sites in Kansas City +24 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07422480·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Bevacizumab

Sites in Kansas City +16 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT06820463·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for Myelodysplastic Syndromes

Sites in Kansas City +21 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06499285·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

for Colorectal Neoplasms

Sites in Kansas City +20 more locations

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT06131840·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

for Locally Advanced Breast Cancer

Sites in Kansas City, St Louis +23 more locations

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06827236·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

for B-cell Acute Lymphoblastic Leukemia

Sites in Kansas City +16 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 6 Months - 25

Code: NCT06395103·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for Malignant Neoplasm

Sites in Kansas City +16 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 1 Month - 17

Code: NCT06941272·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

for Non-small Cell Lung Cancer

Drug: Calderasib

Sites in Kansas City, Springfield +11 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06345729·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

for Breast Cancer

Sites in Kansas City, St Louis +20 more locations

Sponsor: Celcuity Inc

Sex: All·Age: 18+

Code: NCT06757634·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

for Solid Tumor, Adult

Sites in Kansas City, St Louis +17 more locations

Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All·Age: 18+

Code: NCT06625775·Phase 1·Recruiting·Listed Oct 2024

Apply to this trial

Top Research Study Locations in Kansas City

Researchers run research studies in Kansas City, MO at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.

Site	Specializes in	Active trials
University of Kansas Cancer Center - North	Stage IV Lung Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Malignant Solid Neoplasm	48
Children's Mercy Hospital	Bronchopulmonary Dysplasia, Congenital Heart Disease (CHD), Membranous Nephropathy	44
Children's Mercy Hospitals and Clinics	Amblyopia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm	39
University of Kansas Cancer Center - Briarcliff	Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8	35
University Health Truman Medical Center	Anatomic Stage II Breast Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Malignant Solid Neoplasm	34
Saint Luke's Hospital of Kansas City	Breast Cancer, Heart Failure, Acute Kidney Injury	28
Saint Luke's Cancer Institute	Breast Cancer, Breast Neoplasms, Metastatic Breast Cancer	13
Kansas City Veterans Affairs Medical Center	Chronic Lymphocytic Leukemia, RISS Stage I Plasma Cell Myeloma, RISS Stage II Plasma Cell Myeloma	12
Research Medical Center	Atrial Fibrillation, Stroke, Anatomic Stage II Breast Cancer AJCC v8	12
Children's Mercy Kansas City	ALL, Childhood, Behavior, Health, Bronchiolitis Acute	11
Children's Mercy	Acute Brain Injury, Angelman Syndrome, Autism	7
Research Medical Center Clinic	Atrial Fibrillation, Stroke, Aortic Stenosis	7
Kansas City VA Medical Center, Kansas City, MO	Adult Growth Hormone Deficiency, Atherosclerosis, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2	6
St. Luke's Hospital of Kansas City	Amyloid Cardiomyopathy, Amyloidosis, Aortic Stenosis	6
The Children's Mercy Hospital	Alagille Syndrome, Congenital Heart Disease (CHD), Cystic Fibrosis	6
Clinical Trial Site	Angelman Syndrome, Breast Cancer, ER Positive Breast Cancer	5
MidAmerica Cancer Care	Advanced Melanoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms	5
Saint Luke's Mid America Heart Institute	Cardiovascular Diseases, Tricuspid Valve Disease, Heart Failure	5
University of Kansas Medical Center	Smoking Reduction, Idiopathic Pulmonary Fibrosis (IPF), Severe Sepsis	5
Children's Mercy Research Institute	Anorexia Nervosa, Atypical, Binge Eating, Bulimia Nervosa	4
GSK Investigational Site	HIV Infections, Non-alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis	4
Kansas City Research Institute	Chronic Idiopathic Constipation (CIC), Liver Fibrosis, MASH - Metabolic Dysfunction-Associated Steatohepatitis	4
Kansas City VA Medical Center	Heart Failure, End Stage Kidney Disease, Multiple Myeloma	4
Saint Luke's Hospital	Intra-uterine Device Placement, Mitral Valve Prolapse, Mitral Valve Regurgitation (Degenerative or Functional)	4
AMR Clinical	Healthy Adults, Metabolic Dysfunction-Associated Steatotic Liver Disease, Osteoarthritis	3

Active & Upcoming Studies in Kansas City (2026)

Recruiting trials in Kansas City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.

Pediatric (17 active studies)

Neurology & pain (13 active studies)

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Portable MRI for Pediatric Hypoxic Ischemic Brain Injury · Children's Mercy Hospital Kansas City

HIV / STI (7 active studies)

Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment · Phase 2, Phase 3 · Gilead Sciences
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy · Phase 3 · Gilead Sciences

Mental health & behavior (6 active studies)

A Study to Evaluate the Efficacy and Safety of AXS-05 for Smoking Cessation in Adults · Phase 3 · Axsome Therapeutics, Inc.
PTSD Screening in Pregnant Black Women · Emory University

Vaccines (5 active studies)

A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) · Phase 1, Phase 2 · AstraZeneca
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi

Eye & vision (5 active studies)

Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma · Phase 4 · Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,
Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study · Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,

Common conditions studied in Kansas City

Heart Failure (15 active studies)
Breast Cancer (12 active studies)
Malignant Solid Neoplasm (8 active studies)
Acute Myeloid Leukemia (6 active studies)
Chronic Lymphocytic Leukemia (6 active studies)
Obesity (6 active studies)

Leading research sponsors in Kansas City

National Cancer Institute (NCI)
AstraZeneca
Children's Mercy Hospital Kansas City
Children's Oncology Group
Merck Sharp & Dohme LLC

Frequently asked questions

How many paid clinical trials are currently recruiting in Kansas City?

There are approximately 460 recruiting clinical trials in Kansas City, Missouri listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Kansas City pay participants?

Most recruiting trials in Kansas City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Kansas City?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Kansas City?

The most common conditions under active study in Kansas City include Heart Failure (15), Breast Cancer (12), Malignant Solid Neoplasm (8), Acute Myeloid Leukemia (6), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Kansas City?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Kansas City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Kansas City?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Where can I take part in paid clinical trials in Kansas City?

Recruiting research sites in Kansas City include University of Kansas Cancer Center - North, Children's Mercy Hospital, Children's Mercy Hospitals and Clinics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.

What kinds of studies are recruiting in Kansas City right now?

The largest active categories in Kansas City are Cancer & tumors (144), Cardiovascular (56), Diabetes & metabolic (30). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.

Browse more clinical trials

Other cities in Missouri

St Louis, MO(1,410)Columbia, MO(227)Springfield, MO(123)City of Saint Peters, MO(92)Cape Girardeau, MO(86)Creve Coeur, MO(74)Farmington, MO(66)Lee's Summit, MO(66)Sainte Genevieve, MO(65)Sullivan, MO(64)Saint Joseph, MO(57)Chesterfield, MO(52)Osage Beach, MO(47)Joplin, MO(43)Rolla, MO(40)Ballwin, MO(37)Bolivar, MO(35)Washington, MO(30)Saint Charles, MO(29)Branson, MO(28)Sunset Hills, MO(23)Jefferson City, MO(22)Liberty, MO(18)Bridgeton, MO(16)Hazelwood, MO(11)North Kansas City, MO(9)O'Fallon, MO(9)Hannibal, MO(8)Independence, MO(8)Town and Country, MO(5)Fenton, MO(4)Florissant, MO(4)Kirksville, MO(4)Weldon Spring, MO(3)Chillicothe, MO(2)Saint Loius, MO(2)Annapolis, MO(1)Belton, MO(1)Bethany, MO(1)Carrollton, MO(1)Carthage, MO(1)Clinton, MO(1)Des Peres, MO(1)Excelsior Springs, MO(1)Festus, MO(1)Frontenac, MO(1)Kansa City, MO(1)Lake Saint Louis, MO(1)Lebanon, MO(1)Louis, MO(1)Manchester, MO(1)Marshall, MO(1)Overland, MO(1)Overland Park, MO(1)Ozark, MO(1)Poplar Bluff, MO(1)Raymore, MO(1)Raytown, MO(1)Roseville, MO(1)Royal Oak, MO(1)

Related healthcare resources in Missouri

Latest Missouri clinical trials research report

Trials by condition in Kansas City

Heart Failure· 15 Breast Cancer· 12 Acute Myeloid Leukemia· 6 Obesity· 6 Atrial Fibrillation· 5

Conditions in Oncology (Kansas City, MO)

Breast cancer· 20 Non-small cell lung cancer (NSCLC)· 15 Solid tumor· 11 Acute myeloid leukemia (AML)· 7 Metastatic breast cancer· 6 Chronic lymphocytic leukemia (CLL)· 6 Myelodysplastic syndromes (MDS)· 6 Hematologic malignancy· 6 Cancer (any)· 6 Lung cancer· 4 Colorectal cancer· 4 Ovarian cancer· 4 Leukemia (other)· 4 Non-Hodgkin lymphoma· 4 Melanoma· 4 Neuroblastoma· 4 Pancreatic cancer· 3 Esophageal cancer· 3 Gastroesophageal junction cancer· 3 Prostate cancer· 3 Endometrial cancer· 3 Multiple myeloma· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Small lymphocytic lymphoma· 3 Metastatic colorectal cancer· 2 Gastric cancer· 2 Liver cancer· 2 Biliary tract cancer· 2 Bladder cancer· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Mantle cell lymphoma· 2 Sarcoma· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Rhabdomyosarcoma· 2 Neuroendocrine tumors· 2 HER2-positive breast cancer· 1 Colon cancer· 1 Rectal cancer· 1 Metastatic prostate cancer· 1 Kidney cancer· 1 Fallopian tube cancer· 1 Glioblastoma· 1 Myelofibrosis· 1 Follicular lymphoma· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Skin cancer· 1 Head and neck cancer· 1 Thyroid cancer· 1 Pediatric cancer· 1 Mesothelioma· 1

Oncology Clinical Trials in Kansas City, MO

Newly added in Kansas City

90 clinical trials for Oncology

Top Research Study Locations in Kansas City

Active & Upcoming Studies in Kansas City (2026)

Cancer & tumors (144 active studies)

Cardiovascular (56 active studies)

Diabetes & metabolic (30 active studies)

Pediatric (17 active studies)

Neurology & pain (13 active studies)

HIV / STI (7 active studies)

Mental health & behavior (6 active studies)

Vaccines (5 active studies)

Eye & vision (5 active studies)

Common conditions studied in Kansas City

Leading research sponsors in Kansas City

Frequently asked questions

How many paid clinical trials are currently recruiting in Kansas City?

Do clinical trials in Kansas City pay participants?

Who can participate in a clinical trial in Kansas City?

What conditions are most commonly studied in Kansas City?

Are there clinical trials for healthy volunteers in Kansas City?

How do I enroll in a clinical trial in Kansas City?

Where can I take part in paid clinical trials in Kansas City?

What kinds of studies are recruiting in Kansas City right now?

Browse more clinical trials

Other cities in Missouri

Related healthcare resources in Missouri

Trials by condition in Kansas City

Conditions in Oncology (Kansas City, MO)